National Survey on Dyslipidemic Patients (PRYSME)

AstraZeneca

Status: Completed

Conditions: Dyslipidemia

Study type: Observational

Funder types: Industry

Identifiers

NCT00701402

NIS-CFR-DUM-2007/9

Details and patient eligibility

About

The purpose of this observational study is to describe the time to lipid-lowering drug implementation in the management of dyslipidemic patients, according to the cardiovascular risk level.

Enrollment: 3,655 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of dyslipemia made less than 2 years
• Treated by a lipid-lowering drug
• Agree to take part in the survey

Exclusion criteria

• Patient included in a clinical trial